Zoetis Inc (ZTS)
150.88
+1.32
(+0.88%)
USD |
NYSE |
Apr 24, 16:00
151.91
+1.03
(+0.68%)
Pre-Market: 04:27
Zoetis Cash and Short Term Investments (Quarterly): 2.039B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.039B |
| September 30, 2023 | 1.751B |
| June 30, 2023 | 1.714B |
| March 31, 2023 | 2.105B |
| December 31, 2022 | 3.577B |
| September 30, 2022 | 2.503B |
| June 30, 2022 | 2.648B |
| March 31, 2022 | 3.135B |
| December 31, 2021 | 3.482B |
| September 30, 2021 | 3.274B |
| June 30, 2021 | 3.658B |
| March 31, 2021 | 3.602B |
| December 31, 2020 | 3.602B |
| September 30, 2020 | 3.654B |
| June 30, 2020 | 3.353B |
| March 31, 2020 | 1.95B |
| December 31, 2019 | 1.932B |
| September 30, 2019 | 1.823B |
| June 30, 2019 | 1.776B |
| March 31, 2019 | 1.793B |
| December 31, 2018 | 1.696B |
| September 30, 2018 | 1.391B |
| June 30, 2018 | 1.558B |
| March 31, 2018 | 1.654B |
| December 31, 2017 | 1.564B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.981B |
| June 30, 2017 | 705.00M |
| March 31, 2017 | 629.00M |
| December 31, 2016 | 727.00M |
| September 30, 2016 | 651.00M |
| June 30, 2016 | 658.00M |
| March 31, 2016 | 675.00M |
| December 31, 2015 | 1.154B |
| September 30, 2015 | 592.00M |
| June 30, 2015 | 544.00M |
| March 31, 2015 | 559.00M |
| December 31, 2014 | 882.00M |
| September 30, 2014 | 598.00M |
| June 30, 2014 | 578.00M |
| March 31, 2014 | 506.00M |
| December 31, 2013 | 610.00M |
| September 30, 2013 | 389.00M |
| June 30, 2013 | 369.00M |
| March 31, 2013 | 468.00M |
| December 31, 2012 | 317.00M |
| September 30, 2012 | 133.00M |
| June 30, 2012 | 106.00M |
| March 31, 2012 | 113.00M |
| December 31, 2011 | 79.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.714B
Minimum
Jun 2023
3.658B
Maximum
Jun 2021
2.715B
Average
2.648B
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen Inc | 1.050B |
| Eli Lilly and Co | 2.928B |
| Pfizer Inc | 12.69B |
| Abbott Laboratories | 7.279B |
| Bristol-Myers Squibb Co | 12.28B |